Our Pricing

Wegovy Pen Doses Explained: Complete Price Transparency

Searching for a clear wegovy pen doses UK price breakdown? At Cured Pharmacy, we provide complete transparency on Wegovy dosing structure and costs. Each Wegovy pen contains four single-use injections at the same strength, and our pricing from £79.00 reflects genuine UK-licensed medication dispensed after clinical assessment by our registered prescribers.

How Many Doses Are in Each Wegovy Pen?

Every Wegovy pen contains exactly four pre-filled doses at the same strength. This is a critical point many patients misunderstand when comparing costs. Unlike multi-dose vials that require drawing up medication, each Wegovy pen delivers four separate single-use injections, making weekly dosing straightforward and hygienic [1].

The pen design eliminates dosing errors and cross-contamination risks. You'll use one injection per week, meaning each pen lasts precisely four weeks at your prescribed dose level. This standardised format applies across all Wegovy strengths, from the 0.25mg starter dose through to the 2.4mg maintenance dose [1].

Understanding this structure is essential for budgeting your treatment. When you see pricing per pen, you're looking at a four-week supply. Our superintendent pharmacist Tarun Kumar regularly advises patients to calculate monthly costs by dividing the pen price by four to understand the true weekly investment in their weight management programme.

Wegovy Dosing Schedule: The Complete Titration Plan

Wegovy follows a medically supervised dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes. The MHRA-approved titration schedule spans 16 weeks before reaching the maintenance dose, and this gradual increase is not optional—it's a clinical requirement for safety [2].

Your UK prescriber will typically start you at 0.25mg weekly for four weeks, then increase to 0.5mg for four weeks, followed by 1mg, 1.7mg, and finally 2.4mg. Each strength requires its own specific pen, and you'll need a new prescription as you progress through the doses. This structured approach allows your body to adapt to semaglutide's appetite-suppressing effects whilst reducing the likelihood of nausea and vomiting [2].

In the landmark STEP 1 trial, participants following this exact titration schedule achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [3]. The gradual dose increases were instrumental in the 83.5% trial completion rate, demonstrating that proper titration improves both tolerability and treatment adherence.

What Happens If You Miss a Dose?

If you miss your weekly Wegovy injection and fewer than five days have passed, take it as soon as you remember. If more than five days have elapsed, skip that dose entirely and resume your normal schedule with the next planned injection. Never double up doses to compensate for a missed one, as this significantly increases the risk of severe gastrointestinal side effects [1].

Missing multiple consecutive doses may require restarting the titration schedule from a lower strength. Your UK prescriber will assess your individual circumstances and advise whether you can safely resume at your previous dose or need to step back temporarily. This decision depends on how long the treatment gap lasted and your previous tolerance to the medication.

Wegovy Price Breakdown: Understanding UK Costs

At Cured Pharmacy, Wegovy starts from £79.00 per pen, representing a four-week supply at your prescribed strength. This transparent pricing includes your medication, UK prescriber consultation, and discreet home delivery. Unlike some providers, we display costs upfront before you begin your clinical assessment, so you'll never encounter unexpected fees at checkout.

The total investment varies depending on your titration phase. During the initial 16-week escalation period, you'll progress through five different pen strengths, each requiring a separate prescription and supply. Once you reach the 2.4mg maintenance dose, your monthly costs stabilise, making long-term budgeting more predictable. Our pricing structure remains competitive across all dose levels, and we guarantee the lowest prices in the UK market.

Many patients ask why Wegovy costs more than some alternatives. The answer lies in the clinical evidence: semaglutide 2.4mg demonstrated superior weight loss outcomes in head-to-head trials, and the once-weekly injection schedule offers better adherence than daily treatments [3]. Your UK prescriber will help you weigh these factors against cost when determining the most suitable option for your circumstances, subject to clinical eligibility.

How Wegovy Works: The Science Behind Semaglutide

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural gut hormone involved in appetite regulation and glucose metabolism. When you inject semaglutide subcutaneously, it binds to GLP-1 receptors in the brain's appetite centres, reducing hunger signals and increasing feelings of fullness after smaller meals [2].

The medication also slows gastric emptying, meaning food remains in your stomach longer, prolonging satiety between meals. This dual mechanism—central appetite suppression combined with delayed stomach emptying—explains why patients in clinical trials reported eating 20-30% fewer calories without conscious restriction [3]. The once-weekly formulation maintains stable blood levels throughout the week, providing consistent appetite control.

Unlike stimulant-based weight loss medications that increase metabolism or block fat absorption, semaglutide works with your body's existing regulatory systems. This pharmacological approach produces gradual, sustainable weight loss rather than rapid drops that often lead to rebound weight gain. The STEP trials demonstrated that weight loss continued progressively over 68 weeks, with most participants maintaining their reduced weight throughout the study period [3].

Who Can Use Wegovy?

The MHRA has licensed Wegovy for adults with a body mass index (BMI) of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [1]. Your UK prescriber will calculate your BMI during the online consultation and assess whether you meet these clinical criteria.

Wegovy is contraindicated in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. It's also not suitable during pregnancy or breastfeeding, or for patients with severe gastrointestinal disease. Your clinical assessment will screen for these contraindications before a prescription can be issued, ensuring treatment safety.

Wegovy Side Effects: What to Expect

The most common side effects of Wegovy are gastrointestinal: nausea, diarrhoea, vomiting, constipation, and abdominal pain. In the STEP trials, these symptoms affected 44-50% of participants but were typically mild to moderate and decreased significantly after the first few weeks at each new dose level [3]. The gradual titration schedule is specifically designed to minimise these effects.

Less common but more serious side effects include pancreatitis, gallbladder problems, and acute kidney injury secondary to severe dehydration from vomiting or diarrhoea. If you experience severe abdominal pain that doesn't resolve, persistent vomiting, or signs of dehydration (dark urine, dizziness, rapid heartbeat), contact your prescriber or seek immediate medical attention. These complications occur in fewer than 2% of patients but require prompt clinical evaluation [2].

Some patients report injection site reactions—redness, itching, or mild swelling at the injection site. These typically resolve within a few days and can be minimised by rotating injection sites between your abdomen, thigh, and upper arm. Hypoglycaemia is rare in patients without diabetes but can occur if you're taking other glucose-lowering medications concurrently. Your UK prescriber will review all your current medications during consultation to identify potential interactions.

Managing Gastrointestinal Side Effects

If you experience nausea or stomach discomfort, eat smaller, more frequent meals rather than three large ones. Avoid high-fat, fried, or heavily spiced foods, which can exacerbate symptoms. Stay well-hydrated, particularly if you're experiencing diarrhoea or vomiting, and consider ginger tea or other natural remedies that may help settle your stomach.

Most patients find that side effects diminish substantially by the second or third week at each dose level. If symptoms remain severe or interfere with daily activities, contact your prescriber—they may recommend staying at your current dose for an additional month before escalating, or in some cases, stepping back to the previous strength temporarily. Never adjust your dose without clinical guidance.

Getting Started with Wegovy at Cured Pharmacy

Beginning your Wegovy treatment starts with a free online consultation that takes under three minutes to complete. You'll answer questions about your medical history, current medications, weight loss goals, and any contraindications. Our UK-registered prescribers review every consultation individually—this isn't an automated process. If Wegovy is clinically appropriate for you, we'll issue a prescription and dispense your medication the same day in most cases.

We supply only genuine UK-licensed Wegovy manufactured by Novo Nordisk and sourced through MHRA-regulated channels. Every pen arrives in discreet, unmarked packaging with no external indication of contents. You'll receive detailed injection instructions, disposal guidance for used pens, and direct access to our clinical team if you have questions during treatment. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical services, ensuring every aspect of your care meets General Pharmaceutical Council standards.

Ongoing prescriptions are straightforward: as you progress through the titration schedule, you'll complete a brief follow-up consultation before each new dose level. This allows your prescriber to monitor your response, assess any side effects, and confirm you're ready to escalate. Once you reach the 2.4mg maintenance dose, you'll need regular consultations every 12 weeks to continue treatment. We'll send reminders before your prescription expires, so you never experience treatment interruptions.

Scientific References

1. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine licensed by the MHRA for weight management in adults with obesity or overweight with weight-related comorbidities, and must be used alongside a reduced-calorie diet and increased physical activity.